Literature DB >> 21767919

The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.

Hanène Landolsi1, Nabiha Missaoui, Sonia Brahem, Sihem Hmissa, Moez Gribaa, Mohamed Tahar Yacoubi.   

Abstract

Classification of molar gestations into complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM) and their differentiation from nonmolar hydropic abortions (HA) are traditionally accomplished by morphology alone. Sometimes, the process may be inaccurate or inconclusive especially in early diagnosed cases. With the availability of p57(KIP2) immunostaining (the product of a strongly paternally imprinted and maternally expressed gene), it may be possible to classify these lesions objectively. P57(KIP2) immunostaining is absent in CHM because it lacks a maternal genome, whereas PHM and HA show positive staining. The aims of this study were to evaluate the results of routine histopathological examination and p57(KIP2) immunoreactivity in a large series of molar and nonmolar HA in Tunisia, and to compare the accuracy of p57(KIP2) immunohistochemistry with that of nuclear DNA microsatellite polymorphism in identifying CHM. The immunohistochemical expression of p57(KIP2) protein was investigated in 220 specimens of first trimester hydropic abortuses, and it was compared with the original diagnosis based on morphology, including 132 CHM, 49 PHM, and 39 HA. Concordant results were obtained in 210 cases. In 9 of 10 cases with a discordant diagnosis (negative immunostaining in 8 cases morphologically diagnosed as PHM and one case diagnosed as HA), microsatellite DNA genotyping analysis agreed with the results of p57(KIP2) staining, confirming the diagnosis of CHM in these cases. Twenty cases of CHM with negative p57(KIP2) immunostaining were also analyzed by genotyping and indicated the absence of maternal contribution and the homozygosity for a single paternal allele in concordance with the androgenetic and monospermic origin of CHM in these cases. We confirm that for distinguishing CHM from its mimics, p57(KIP2) immunohistochemistry can be used as successfully as DNA microsatellite genotyping. However, molecular techniques are still required for the evaluation of some difficult cases with discordant positive p57(KIP2) staining.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767919     DOI: 10.1016/j.prp.2011.06.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  A cornual invasive hydatiform mole: A literature review.

Authors:  A Khlifi; I Mkhinini; M T Yaacoubi; H Khairi
Journal:  Med J Armed Forces India       Date:  2016-02-23

2.  Identification of a hydatidiform mole in twin pregnancy following assisted reproduction.

Authors:  Yan Liu; Xingzheng Zheng; Yuxiang Wang; Yan Li; Congrong Liu
Journal:  J Assist Reprod Genet       Date:  2019-12-12       Impact factor: 3.412

3.  Variable Number Tandem Repeat (VNTR) Genotyping of Hydatidiform Mole in Iranian Patients.

Authors:  Zahra Pakzad; Hossein Mozdarani; Narges Izadi-Mood; Shirin Niromanesh
Journal:  Avicenna J Med Biotechnol       Date:  2014-10

4.  Morphological Features and Immunohistochemical Expression of p57Kip2 in Early Molar Pregnancies and Their Relations to the Progression to Persistent Trophoblastic Disease.

Authors:  Marwa Khashaba; Mohammad Arafa; Eman Elsalkh; Reda Hemida; Wagiha Kandil
Journal:  J Pathol Transl Med       Date:  2017-06-12

5.  Accuracy of p57KIP2 compared with genotyping for the diagnosis of complete hydatidiform mole: protocol for a systematic review and meta-analysis.

Authors:  Jose Mauro Madi; Antonio Rodrigues Braga; Machline Paim Paganella; Isnard Elman Litvin; Eliana Márcia Da Ros Wendland
Journal:  Syst Rev       Date:  2016-10-04

6.  Accuracy of p57KIP2 compared with genotyping to diagnose complete hydatidiform mole: a systematic review and meta-analysis.

Authors:  J M Madi; A Braga; M P Paganella; I E Litvin; E M Wendland
Journal:  BJOG       Date:  2018-06-15       Impact factor: 6.531

7.  p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.

Authors:  Helle Lund; Søren Nielsen; Anni Grove; Mogens Vyberg; Lone Sunde
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-10

8.  Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.

Authors:  Melisa Lelic; Zlatan Fatusic; Ermina Iljazovic; Suada Ramic; Sergije Markovic; Selma Alicelebic
Journal:  Med Arch       Date:  2017-08

9.  Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole.

Authors:  Rishi Raj; Edilfavia Mae Uy; Matthew Hager; Kamyar Asadipooya
Journal:  Case Rep Endocrinol       Date:  2019-12-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.